In medium spiny neurons (MSNs) 
Introduction
Two classes of L-type Ca 2+ channel (LTC) α 1 subunits are expressed in the brain: α 1C (Ca V 1.2) and α 1D (Ca V 1.3) [1] with highest expression in cerebral cortex and striatum [2] . While differing in biophysical properties and pharmacological sensitivities, both LTCs contribute to Additionally, D 2 R activation releases arachidonic acid (AA) in vivo [17] [18] [19] [20] , in primary neurons [21] and in transfected cell lines [22] . Our laboratory has demonstrated that exogenously applied AA inhibits LTC currents in superior cervical ganglion neurons (SCG) [23] [24] [25] . These currents are most likely exclusively due to Ca V 1.3 current [26] . Additionally, we have shown that AA inhibits recombinant Ca V 1.3 currents when expressed in HEK293 cells [27] . Therefore, a second D 2 R signaling pathway inhibiting Ca V 1.3 may involve activation of Ca 2+ --dependent cytosolic phospholipase A 2 (cPLA 2 ), which cleaves AA from phospholipids, similar to M 1 muscarinic receptor (M 1 R) modulation of LTC current in SCG [25] .
In the present study, we developed a model system to probe the D 2 R signaling pathway inhibiting Ca V 1.3 using the ST14A cell line, created from embryonic rat striatum [28] . Retroviral transduction of the temperature-sensitive SV40 large T antigen enables ST14A cells to grow and divide at the permissive temperature of 33°C. At higher temperatures the cells differentiate to exhibit general neuronal, as well as specific MSN-like, properties including functional D 2 -like receptors [28, 29] . We examined whether ST14A cells express identified signaling molecules downstream of D 2 Rs in an effort to develop a model cell line with MSN properties to study the functional effects of D 2 R signaling on Ca V 1.3. We found that round ST14A cells lacked endogenous Ca 2+ current and exploited this deficiency by transfecting cells with Ca V 1.3 and accessory subunits, thus eliminating the need for pharmacological blockers. Recombinant Ca V 1.3 currents were characterized and tested for current modulation by the D 2 dopamine agonist quinpirole and by exogenous AA.
Materials and Methods

Preparation of Cells
The ST14A cell line, created by Elena Cattaneo and described in Cattaneo and Conti, 1998 [28] , was given to us as a gift from Dr. Michelle E. Ehrlich (Jefferson Medical School) with permission from Dr. Elena Cattaneo (University of Milano). ST14A cells were propagated at the permissive temperature of 33°C in Dulbecco's modified Eagle's medium (DMEM; Gibco) supplemented with 0.11 g/L sodium bicarbonate (Sigma, St. Louis, MO), 0.29 g/L L-glutamine, 3.9 g/liter HEPES, 100 units/ml penicillin-streptomycin, and 10% fetal bovine serum (FBS; Invitrogen, Carlsbac, CA). Cells were transferred to 37°C to promote differentiation and used 1-2 days later. The A9L cell line, derived from A9 L cells co-transfected with the human D 2 R and obtained from the American Type Culture Collection (ATCC, Manassas, VA), were propagated at 37°C in DMEM with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate and 4.5 g/L glucose containing 10% FBS. HEK 293 cells were propagated at 37°C in DMEM/F12 containing 10% FBS. All cells were maintained in a temperature-controlled humidified incubator at 5% CO 2 FPL 64176 and nimodipine were prepared as stock solutions in 100% ethanol and stored at -20°C. AA (5,8,11,14- eicosatetraenoic acid; NuCheck Prep, Elysian, MN) and oleic acid (NuCheck Prep) were dissolved in 100% ethanol and stored under nitrogen as stock solutions at -70°C. ω-conotoxin GVIA (Bachem, Torrence, CA) and quinpirole were prepared as stock solutions in double distilled water and stored at -70°C. Oxotremorine-M (Tocris, Ellisville, MO) was prepared fresh daily by making a 10 mM stock in double distilled water. Working dilutions were made fresh daily by diluting stock solutions at least 1:1,000 with external bath solution. For ethanol prepared stocks, the final ethanol concentration was less than 0.1%. Bovine serum albumin (BSA; fraction V, heat shock, fatty acid ultra-free; Roche Applied Science, Indianapolis, IN) was added directly to the bath solution for a final concentration of 1 mg/ml. All chemicals were purchased from Sigma unless otherwise noted.
Data were acquired using Signal 2.14 software (Cambridge Electronic Design, Cambridge, England) and stored for later analysis on a personal computer. Linear leak and capacitive currents were subtracted from all traces. Data are presented as the mean ± s.e.m. Significance was determined statistically using a two-tailed paired or unpaired t-test, or a one-way ANOVA. Analysis programs include Signal (Cambridge Electronic Design), Excel (Microsoft, Redmond, WA) and Origin (OriginLab, Northampton, MA).
Transfection
ST14A cells were transfected by lipofectamine (Invitrogen, Carlsbad, CA) with a 1:1:1 molar ratio of Ca V 1.3, β 2a , and α 2 δ subunits [30] . Constructs for Ca V 1.3b (+exon11, Δexon32, +-exon42a; GenBank accession #AF370009), and α 2 δ-1 (GenBank accession #AF286488) were a gift from Dr. Diane Lipscombe (Brown University) and the construct for Ca V β 2a (GenBank accession #M80545) was a gift from Dr. Edward Perez-Reyes (University of Virginia). For all transfections, 0.4 μg of DNA was used per well of a 12-well plate. Prior to transfection, cells were washed with DMEM. The DNA mixture was then added dropwise to each well, gently swirled then incubated for 1-3 h at 37°C in a 5% CO 2 incubator. Supplemented media, without antibiotics, was returned to the wells to bring the volume up to 1 ml (normal growth medium volume). Cells were washed with full media 2 and 4 h later and assayed for transient gene expression after 24-72 h.
Reverse Transcriptase-Polymerase Chain Reaction
Homogenized tissue samples (50-100 mg) or confluent cells in a 100 mm dish were lysed in 1 ml TRIzol Reagent (Invitrogen). RNA was separated from DNA by phenol-chloroform phase separation. RNA was precipitated with isopropyl alcohol and washed with 75% ethanol. The RNA pellet was dried and resuspended in RNase-free water. RNA samples had an A 260 /A 280 ratio between 1.6 and 1.8 and were treated with DNase to eliminate contamination with genomic DNA. For reverse transcription, cDNA was synthesized from the mRNA by adding 1 μl 10X buffer RT, 1 μl dNTP Mix (5 mM each dNTP), 1 μl Oligo-dT primer (0.5 mg/ml, Promega, Madison, WI), 0.125 μl RNase Inhibitor (40 U/μl, Promega), 0.5 μl Omniscript Reverse Transcriptase (4 U/μl) and RNase-free water for a total volume of 10 μl (all reagents from QIAGEN, Valencia, CA, unless otherwise noted). The mixture was incubated at 37°C for 1 h. The mixture was then heated at 93°C for 5 min and then placed on ice to inactivate the transcriptase. PCR amplification was then performed with a Techgene thermal cycler (Techne Inc, Burlington, NJ) with thin walled PCR tubes.
PCR primers for dopamine receptors D 1 -D 5 (D 5 formerly referred to as D 1b ) were sequences previously published [31] . D 1 : 5'-GAC AAC TGT GAC ACA AGG TTG AGC-3' and 5'-ATT ACA GTC CTT GGA GAT GGA GAT GGA GCC-3' yields a 609 base pair (bp) product. D 2 : 5'-GCA GTC GAG CTT TCA GAG CC-3' and 5'-TCT GCG GCT CAT CGT CTT AAG-3' yields 404 and 317 bp products recognizing the long and short forms of the D 2 R, respectively. D 3 : 5'-AGC ATC TGC TCC ATC TCC AAC CC-3' and 5'-A GGA GTT CCG AGT CCT TTC CAC G-3' yields a 461 bp product. D 4 : 5'-TC ATG CTA CTG CTT TAC TGG GCC A-3' and 5'-T CTG AGA GAG GTC TGA CTC TGG TC-3' yields a 223 bp product. D 5 : 5'-AGT CGT GGA GCC TAT GAA CCT GAC-3' and 5'-GCG TCG TTG GAG AGA TTT GAG ACA-3' yields a 517 bp product. GAD65 and GAD67 primers were from sequences previously published [32] . GAD65: 5'-CGC CCC TGT ATT TGT ACT AC-3' and 5'-GCC AAG AGA GGA TCA AAA GC-3' yields a 400 bp product. GAD67: 5'CAC ACC AGT TGC TGG AAG-3' and 5'-ACA AAC ACG GGT GCA ATT-3' yields 318 and 238 bp products. GAPDH primers were from sequences previously published [33] . GAPDH: 5'-TGC CAA GGC TGT GGG CAA GG-3' and 5'-GCT TCA CCA CCT TCT TGA TG-3' yields a 199 bp product and confirmed equal loading.
Reaction mixtures for PCR contained 200 ng of cDNA, 5 μl of 2.5 X Eppendorf MasterMix [Taq DNA Polymerase (62.5 U/ml), 125 mM KCl, 75 mM Tris-HCl, 3.75 mM Mg(OAc) 2 , 0.25% Igepal-CA630, 500 μM of each dNTP and stabilizers, Brinkmann, Westbury, NY], 1 μl each of forward and reverse primer (5 pmol/ μl, Invitrogen for dopamine receptors and GAD; Qiagen for GAPDH), 2 to 4 mM Mg 2+ (Brinkmann) and distilled water to a final volume of 12.5 μl. High (4 mM) Mg 2+ concentrations were necessary to amplify dopamine receptor mRNAs. The protocol for dopamine receptor amplification was 94°C for 1 min, 58°C for 1 min, and 72°C for 3 min for 20 cycles [31] . For the D 3 R, an annealing temperature of 62°C was also tried. For GAD amplification, the protocol was 94°C for 3 min, 53°C for 1 min, 52°C for 1 min, 51°C for 1 min, and 70°C for 2 min for 30 cycles [32] . A 2 μl aliquot was used as a template for a second round of amplification for thirty cycles. PCR products and a 100 bp DNA ladder (Invitrogen; bright band 600 bp or Promega, Madison, WI; bright band 500 bp) were separated by electrophoresis in 2% agarose gels stained with ethidium bromide. Bands excised from gels were sequenced by the UMASS Medical School Nucleic Acid Facility and compared to published sequences (GenBank accession number):
, and GAD67 (M81883).
Western Blot Analysis
The immunoblot protocol has been previously described [34] . All extracts and buffers contained protease inhibitors (Santa Cruz Biotechnology, Santa Cruz, CA): pepstatin A (1μg/ml), leupeptin (10 μg/ml), aprotinin ( 
Results
To determine if ST14A cells express endogenous Ca 2+ current, we measured whole-cell currents from cells grown at 33 or 37°C. Two populations of cells were distinguished based on morphology: round or differentiated, with the definition of having neuron-like projections. From a holding potential of -90 mV, round cells exhibited zero to little endogenous peak or tail current measured at +10 mV or -40 mV respectively, regardless of the temperature at which the cells were grown ( Fig 1A) . Differentiated cells had significantly more endogenous current than round cells at both potentials (Fig 1B) . Application of the LTC agonist, FPL 64176 (FPL; 1 μM) enhanced endogenous currents at both potentials (Fig 1A and 1B) , indicating that at least a component of the endogenous current was LTC. Since round cells showed little to no LTC current, we transfected the ST14A cells with LTC channel subunits, Ca V 1.3, β 2a , and α 2 δ-1, along with green fluorescent protein (GFP) and recorded whole-cell currents from green fluorescing round cells (Fig 1C) . Peak and tail currents from round transfected cells were significantly larger than those recorded from round untransfected cells (Fig 1A and 1B) . FPL significantly enhanced recombinant current at -40 mV. Fig 1D shows representative individual traces of round endogenous or round recombinant current before and after application of FPL. The recombinant current shows little to no inactivation with 20 mM Ba 2+ as the charge carrier [35] , typical of LTC current coexpressed with the accessory subunit, β 2a [36] . Since Ca V 1.3 activates at more negative voltages compared to Ca V 1.2 [30] , we measured peak current at -10 mV. Recombinant current recorded at -10 mV was larger than at +10 mV exhibited little to no current and were pooled. Currents were recorded from round ST14A cells grown at 33°C, transfected and grown at 37°C for at least 24 hours before recording. Each set of cells were recorded in the absence (white bars) and presence of 1 μM FPL (black bars). Summary of peak Ca 2+ currents measured from a holding potential of -90 mV to a test potential of +10 mV (A) and then to a tail potential of -40 mV (B).
( Fig 1A) and this increase was also reflected in the tail current amplitude at -40 mV (Fig 1B) . The summary of these results shows that round ST14A cells have little endogenous LTC current but are capable of being transfected with LTCs and expressing functional LTC currents. Therefore, the round cells represent a population of ST14A cells that we used to study recombinant LTC function in isolation from other types of native Ca 2+ channels.
We characterized recombinant Ca V 1.3 current further to determine whether transfected channel activity in ST14A cells exhibits biophysical and pharmacological properties of Ca V 1.3 observed in oocytes and HEK 293 cells [30] . First, we measured peak current across a range of voltages to show that channels open at relatively negative voltages compared to Ca V 1.2 [30] . Indeed, in 20 mM Ba 2+ , Ca V 1.3 currents activated at a test potential of -60 mV and peaked at -10 mV to 0 mV (Fig 2A) . Recombinant current in ST14A cells exhibited a Ca V 1.3 LTC pharmacological profile. To determine whether D 2 R activation by the agonist quinpirole (Quin) inhibits Ca V 1.3 currents in ST14A cells, we recorded recombinant currents in the presence of FPL to enhance current amplitude. At a concentration of 10 μM, Quin had no significant effect on peak or tail current amplitude over time, (Fig 3A left) or in individual traces (Fig 3A right) . To determine if only recombinant Ca V 1.3 current was insensitive to D 2 R activation, we tested whether endogenous ST14A current from differentiated cells could undergo modulation. Again 10 μM Quin had no significant effect on endogenous peak or long-lasting tail current amplitude. Fig 3B  shows representative current traces in the presence of 1 μM FPL from a range of voltages before and after Quin. Since a majority of MSNs express muscarinic M 1 receptors (M 1 Rs) as well as dopamine receptors [37] , we tested whether activation of this receptor would inhibit endogenous current. The muscarinic agonist oxotremorine-M (Oxo-M; 10 μM) had no effect on endogenous peak or long-lasting tail current amplitude. Fig 3C shows representative current traces in the presence of FPL from a range of voltages (-60 mV to -10 mV) tested before and after Oxo-M. Fig 3D summarizes phosphorylation in ST14A cells, indicating that D 2 Rs do couple to intact signaling cascades such as the adenylyl cyclase and MAPK pathways [29] .
A non-selective D 2 R-like agonist, Quin also activates D 3 and D 4 Rs [38] . Subsequently, D 3 and D 4 Rs modulate immediate early gene expression [39, 40] 293 cells (negative control for all dopamine receptors). PCR products were detected for long and short splice variants of the D 2 R in ST14A cells (n = 4/11 and 2/11, respectively, striatum (n = 1/2 and 2/2, respectively), cortex (n = 1/2 for both) and A9L cells (n = 2/5 and 2/5, respectively) as shown in Fig 4A. Additionally, D 1 R (n = 2/10), D 4 R (7/10), D 5 R (4/10) (data not shown) mRNAs were also detected in ST14A cells, regardless of the temperature at which cells were grown. D 1 R, D 4 R and D 5 R mRNAs were detected in striatum whereas D 1 R and D 4 R mRNAs were detected in the cortex (data not shown). D 4 R mRNA was also detected in A9L cells (n = 3/4). Experiments for D 3 R mRNA expression in striatum, cortex, and ST14A cell samples resulted in a smear despite several attempts to adjust the protocol. HEK 293 cells showed no expression of any of the dopamine receptors tested. These results show that ST14A cells express mRNA for more than one D 2 -like receptor; this finding could account for the previously reported D 2 R-like changes in pCREB [29] .
Since MSNs are GABAergic, a defining characteristeric of ST14A cells being MSN-like would be expression of glutamic acid decarboxylase (GAD), the enzyme that catalyzes GABA synthesis from glutamate. Using RT-PCR, we measured whether ST14A cells express GAD2 and GAD1, two genes which encode GAD with molecular weights of 65 and 67 kDa, respectively. The primers used against GAD1 detect both embryonic and adult splice forms of GAD67. All three bands corresponding to GAD65 and embryonic and adult GAD67 were detected in ST14A cells (Fig 4B) . Alternate lanes in which RNA samples were not reverse transcribed served as controls for genomic DNA contamination and yielded no product. Using striatal and cortical tissues as positive controls for the GAD genes, and in A9L cells, we detected all three forms of GAD as well. In contrast, no bands for GAD65 and only faint bands for GAD67 were detected in HEK 293 cells. The presence of GAD in ST14A cells further confirms that this cell line exhibits GABAergic characteristics of MSNs.
After confirming ST14A cells exhibit a similar mRNA expression profile for dopamine receptors and GAD as MSNs, we examined whether D 2 Rs and downstream signaling molecules were expressed in ST14A cells. Using Western blot analysis, D 2 R and M 1 R expression was confirmed in ST14A cells. D 2 R antibodies recognized a band at 50 kDa, the expected molecular weight of D 2 Rs (Fig 5A, top panel) for striatum and cortex (positive controls). A second band at 75 kDa, absent in the A9L cell line, most likely represents a glycosylated form of the receptor [41] , further supporting the idea that the ST14A cells are similar to neurons in these brain regions regarding post-translational modification of proteins. Fig 5A (middle panel) shows that ST14A cells, but not A9L cells, express M 1 Rs, displayed as a 50 kDa band on Western blots. This antibody recognized M 1 R expression in SCG, striatum, and cortex [34] . Expression of G q α (Fig 5A, bottom panel) , which couples to M 1 Rs, was also detected in the cell lines and tissue samples at the predicted molecular weight of 42 kDa. These results show that ST14A cells express D 2 R, M 1 R and G q α proteins.
Since D 2 Rs and M 1 Rs both couple to PLCβ-1, we examined whether ST14A cells express PLCβ-1. Protein expression of PLCβ-1 was not detected in either the A9L or ST14A cell lines, but was detected in SCG tissue (Fig 5B) . The unanticipated absence of PLCβ-1 may account for the lack of Ca V 1.3 modulation since PLCβ-1 is required for LTC current inhibition by both the D 2 R and M 1 R pathways [10, 42] . To determine the presence of molecules downstream of PLCβ-1 reported to participate in LTC modulation by these receptors [10, 25] , we tested for cPLA 2 and PP2B expression. Fig 5C shows that ST14A cells cultured at 33 and 37°C, as well as A9L cells, express cPLA 2 . cPLA 2 was detected at low expression levels from postnatal day 1 SCG (positive control) as has been reported previously [25] . Fig 5D shows that ST14A cells also express PP2B. Since PLCβ-1 is downstream of both D 2 and M 1 Rs, this result may explain our lack of inhibition of Ca V 1.3 or endogenous LTC current by Quin or Oxo-M in ST14A cells. To circumvent the absence of a key signaling molecule, and determine whether Ca V 1.3 could be modulated, we directly applied exogenous AA (10 μM) to the bath and measured Ca V 1.3 recombinant current over several minutes. In the presence of FPL, AA inhibited Ca V 1.3 peak and long-lasting tail currents by 40 ± 12% and 29 ± 25% respectively after 1 min (n = 4). Fig 6A shows representative sweeps before (FPL) and after AA application (FPL + AA). The large variability in tail current inhibition by AA suggested that voltage may be important for this modulation. However, AA inhibited Ca V 1.3 current at all voltages when tested over a range of test potentials as shown in the I-V plot in Fig 6B. Bovine serum albumin (BSA), which binds free fatty acids [43] , reversed inhibition at all test potentials. To show that inhibition was not due to AA competing with FPL, we measured Ca V 1.3 current in the absence of FPL prior to and after application of AA (Fig 6C) and still observed inhibition that could be reversed after adding BSA. Inhibition of Ca V 1.3 over time by AA (open bars) and recovery by BSA (solid bar) is summarized in Fig 6D. Conversely, oleic acid (10 μM) enhanced current by 7.9 ± 0.7% after 1 minute (Fig 6E; p < 0.001; n = 3), suggesting that inhibition by AA is not simply the result of a nonspecific fatty acid effect. Moreover, inhibition of Ca V 1.3 by AA demonstrates that the transfected Ca V 1.3 LTCs in ST14A cells are capable of modulation.
Discussion
MSNs have a resting membrane potential that oscillates between~-85 mV (during the "down" state) and~-60 mV (during the "up" state) [4, 6] . Inhibition of Ca V 1.3 is of particular interest in MSNs because it activates at potentials approximately 25 mV more negative than Ca V 1.2, [30] . Since Ca V 1.3 activates at the low voltage of -60 mV, this channel may open during the "up" state and contribute to reaching threshold for firing an action potential [4] . Moreover, increased D 2 R signaling or inhibition of LTCs in MSNs decreases membrane excitability [10] . MSN activity produces the only output from the striatum and thus the finely tuned regulation of MSN activity is critical for normal motor function. Disruption of MSN regulation results in severe malfunction of the basal ganglia, as seen when MSNs lose dopaminergic input in Parkinson's disease, or when MSNs undergo cell death as seen in Huntington's disease [5, 44] .
Because studying Ca 2+ currents in MSNs has been challenging, we searched for a cell line that might serve as a model system for MSNs. However, remarkably few neuronal cell lines have been developed despite ongoing demand for their use in biophysical studies of ion channels and in high through put systems for therapeutic drug testing. [29, [48] [49] [50] [51] . Moreover these cells express other enzymes that act on lipids including N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (NAPE-PLD), fatty acid amide hydrolase, diacylglyceride lipase, monoacylglycerol lipase (Bari et al., 2013) , and cPLA 2 (Fig 3C) .
The absence of PLCβ-1 expression in ST14A cells coincides with the lack of Ca V 1.3 current inhibition by either Quin or Oxo-M, supporting the importance of PLCβ-1 for both D 2 R and M 1 R signal transduction pathways [10, 52, 53] . Despite PLCβ-1's absence, it was not obvious that no other variant of PLCβ would substitute for the missing PLCβ-1. The absence of PLCβ-1 and its apparent requirement for D 2 R signaling will be of interest to researchers who study MSNs. Interestingly, PLCβ-1 has been implicated in regulating growth and proliferation, where its absence results in uncontrolled cell proliferation [54, 55] . Thus a loss of PLCβ-1 may have occurred during the immortalization of ST14A cells.
In these experiments, we used a short splice variant of Ca V 1.3, Ca V 1.3b [30] . Ca V 1.3a, which has a longer C-terminus, was not inhibited by activation of D 2 Rs when expressed in HEK 293 cells [56] ; however, Ca V 1.3a has been shown to bind the scaffolding protein Shank found in the postsynaptic density of synapses [57] . This association is necessary for Ca V 1.3 current inhibition by D 2 Rs in primary MSNs [11] . Although the lack of the long C-terminus also could explain the absence of channel modulation by D 2 Rs in ST14A cells, Ca V 1.3b LTCs can be modulated by both IGF-1 and AA. Exposure of SH-SY5Y cells expressing either Ca V 1.3a or Ca V 1.3b to IGF-1 enhances both currents and requires phosphorylation of S1486, a residue shared by both splice variants [58] . We have measured significant Ca V 1.3b inhibition by AA in transiently transfected HEK 293 cells, consistent with a potential transmembrane site of action [27] .
Since AA release occurs in the striatum from both neurons and astrocytes [59] [60] [61] following stimulation of D 2 Rs [21] or M 1 Rs [62] , we tested whether bath application of AA modulated LTC in ST14A cells to be certain that Ca V 1.3b could be modulated by molecules downstream of PLCβ-1. We were unsure whether AA would inhibit Ca V 1.3b channels in ST14A cells similarly to Ca V 1.3 channels in HEK 293 cells [27] or native LTCs in SCG neurons [23] [24] [25] since a wide range of actions have been reported for AA modulation of a variety of Ca 2+ currents by other groups (see review by Roberts-Crowley et al [63] ). We found that direct application of AA circumvented the lack of receptor-activated channel modulation in ST14A cells and inhibited Ca V 1.3b recombinant current. This finding demonstrates that Ca V 1.3 channels are capable of being modulated in ST14A cells as we have observed previously in HEK 293 cells [27] . 
Conclusions
ST14A cells are used as a model system for both the study and treatment of Huntington's disease [64] [65] [66] [67] [68] [69] . Despite the lack of D 2 R-or M 1 R-mediated Ca 2+ channel modulation in ST14A cells reported here, this cell line was useful for elucidating that AA inhibits Ca V 1.3 channels. We hypothesize that the consistency of AA's inhibitory actions on Ca V 1.3 across cell types will be of interest to researchers who study lipid signaling molecules. Moreover, we anticipate the D 2 R signaling cascade could be rescued by transfecting ST14A cells with PLCβ-1. Whether D 2 R signaling would then cause a lipid mediated inhibition of Ca V 1.3b LTCs awaits future studies. Thus, ST14A cells are a valuable tool for studying the biophysical properties of an isolated Ca 2+ current and the modulation of these channels by signaling molecules within the context of a striatal background to aid in understanding neuronal malfunctions of the striatum.
